Gene amplification is one of the mechanisms underlying the activation of proto-oncogenes such as ERBB2, CCND1, CCNE1, MDM2, and E2F3, which have been suggested as cancer driver genes in bladder cancers, based on their aberrant gene amplification and protein overexpression [5,19–22]. Here, CCND1 is linked to urinary bladder carcinoma.